|
2025-02-25 |
2025-02-21 |
PS
Planned sale
|
Morrell Martha
CHIEF MEDICAL OFFICER
Officer
|
78,334
-48.9%
13.72
USD 1,074,844
|
78,334
-48.9%
|
13.72
|
USD 1,074,844
|
|
|
2025-02-20 |
2025-02-20 |
S
Sale
|
KCK LTD.
Large shareholder
|
5,270,845
-100.0%
9.40
USD 49,545,943
|
5,270,845
-100.0%
|
9.40
|
USD 49,545,943
|
|
|
2025-01-31 |
2025-01-30 |
PS
Planned sale
|
Morrell Martha
CHIEF MEDICAL OFFICER
Officer
|
200
-0.2%
15.00
USD 3,000
|
200
-0.2%
|
15.00
|
USD 3,000
|
|
|
2025-01-31 |
2025-01-29 |
PS
Planned sale
|
Morrell Martha
CHIEF MEDICAL OFFICER
Officer
|
100
-0.1%
15.00
USD 1,500
|
100
-0.1%
|
15.00
|
USD 1,500
|
|
|
2025-01-28 |
2025-01-24 |
PS
Planned sale
|
Morrell Martha
CHIEF MEDICAL OFFICER
Officer
|
3,200
-3.5%
15.01
USD 48,032
|
3,200
-3.5%
|
15.01
|
USD 48,032
|
|
|
2024-10-28 |
2024-10-25 |
S
Sale
|
KCK LTD.
Large shareholder
|
223,991
-4.1%
5.45
USD 1,221,042
|
223,991
-4.1%
|
5.45
|
USD 1,221,042
|
|
|
2024-10-28 |
2024-10-23 |
S
Sale
|
KCK LTD.
Large shareholder
|
147
-0.0%
6.02
USD 885
|
147
-0.0%
|
6.02
|
USD 885
|
|
|
2024-10-24 |
2024-10-22 |
S
Sale
|
KCK LTD.
Large shareholder
|
4,082
-0.1%
6.09
USD 24,853
|
4,082
-0.1%
|
6.09
|
USD 24,853
|
|
|
2024-10-22 |
2024-10-21 |
S
Sale
|
KCK LTD.
Large shareholder
|
3,720
-0.1%
6.10
USD 22,679
|
3,720
-0.1%
|
6.10
|
USD 22,679
|
|
|
2024-10-22 |
2024-10-18 |
S
Sale
|
KCK LTD.
Large shareholder
|
4,878
-0.1%
6.29
USD 30,692
|
4,878
-0.1%
|
6.29
|
USD 30,692
|
|
|
2024-10-18 |
2024-10-17 |
S
Sale
|
KCK LTD.
Large shareholder
|
3,294
-0.1%
6.28
USD 20,686
|
3,294
-0.1%
|
6.28
|
USD 20,686
|
|
|
2024-10-18 |
2024-10-16 |
S
Sale
|
KCK LTD.
Large shareholder
|
6,900
-0.1%
6.57
USD 45,336
|
6,900
-0.1%
|
6.57
|
USD 45,336
|
|
|
2024-10-18 |
2024-10-15 |
S
Sale
|
KCK LTD.
Large shareholder
|
4,017
-0.1%
6.50
USD 26,098
|
4,017
-0.1%
|
6.50
|
USD 26,098
|
|
|
2024-10-18 |
2024-10-14 |
S
Sale
|
KCK LTD.
Large shareholder
|
4,031
-0.1%
6.54
USD 26,360
|
4,031
-0.1%
|
6.54
|
USD 26,360
|
|
|
2024-10-18 |
2024-10-11 |
S
Sale
|
KCK LTD.
Large shareholder
|
2,572
-0.0%
6.35
USD 16,320
|
2,572
-0.0%
|
6.35
|
USD 16,320
|
|
|
2024-10-18 |
2024-10-10 |
S
Sale
|
KCK LTD.
Large shareholder
|
2,504
-0.0%
6.12
USD 15,317
|
2,504
-0.0%
|
6.12
|
USD 15,317
|
|
|
2024-10-18 |
2024-10-09 |
S
Sale
|
KCK LTD.
Large shareholder
|
3,123
-0.1%
6.10
USD 19,065
|
3,123
-0.1%
|
6.10
|
USD 19,065
|
|
|
2024-10-18 |
2024-10-08 |
S
Sale
|
KCK LTD.
Large shareholder
|
6,000
-0.1%
6.43
USD 38,552
|
6,000
-0.1%
|
6.43
|
USD 38,552
|
|
|
2024-10-18 |
2024-10-07 |
S
Sale
|
KCK LTD.
Large shareholder
|
4,910
-0.1%
6.66
USD 32,687
|
4,910
-0.1%
|
6.66
|
USD 32,687
|
|
|
2024-10-18 |
2024-10-04 |
S
Sale
|
KCK LTD.
Large shareholder
|
5,757
-0.1%
6.92
USD 39,830
|
5,757
-0.1%
|
6.92
|
USD 39,830
|
|
|
2024-10-18 |
2024-10-03 |
S
Sale
|
KCK LTD.
Large shareholder
|
3,318
-0.1%
6.97
USD 23,115
|
3,318
-0.1%
|
6.97
|
USD 23,115
|
|
|
2024-10-03 |
2024-10-02 |
S
Sale
|
KCK LTD.
Large shareholder
|
3,843
-0.1%
6.87
USD 26,401
|
3,843
-0.1%
|
6.87
|
USD 26,401
|
|
|
2024-10-03 |
2024-10-01 |
S
Sale
|
KCK LTD.
Large shareholder
|
4,882
-0.1%
6.77
USD 33,051
|
4,882
-0.1%
|
6.77
|
USD 33,051
|
|
|
2024-10-03 |
2024-09-30 |
S
Sale
|
KCK LTD.
Large shareholder
|
4,749
-0.1%
6.73
USD 31,961
|
4,749
-0.1%
|
6.73
|
USD 31,961
|
|
|
2024-10-03 |
2024-09-27 |
S
Sale
|
KCK LTD.
Large shareholder
|
5,059
-0.1%
6.63
USD 33,541
|
5,059
-0.1%
|
6.63
|
USD 33,541
|
|
|
2024-10-03 |
2024-09-26 |
S
Sale
|
KCK LTD.
Large shareholder
|
5,821
-0.1%
6.62
USD 38,535
|
5,821
-0.1%
|
6.62
|
USD 38,535
|
|
|
2024-10-03 |
2024-09-25 |
S
Sale
|
KCK LTD.
Large shareholder
|
5,858
-0.1%
6.60
USD 38,663
|
5,858
-0.1%
|
6.60
|
USD 38,663
|
|
|
2024-10-03 |
2024-09-23 |
S
Sale
|
KCK LTD.
Large shareholder
|
282
-0.0%
7.54
USD 2,126
|
282
-0.0%
|
7.54
|
USD 2,126
|
|
|
2024-10-03 |
2024-09-20 |
S
Sale
|
KCK LTD.
Large shareholder
|
765
-0.0%
7.50
USD 5,738
|
765
-0.0%
|
7.50
|
USD 5,738
|
|
|
2024-10-03 |
2024-09-13 |
S
Sale
|
KCK LTD.
Large shareholder
|
1,993
-0.0%
7.59
USD 15,127
|
1,993
-0.0%
|
7.59
|
USD 15,127
|
|
|
2024-10-03 |
2024-09-06 |
S
Sale
|
KCK LTD.
Large shareholder
|
11
-0.0%
7.50
USD 83
|
11
-0.0%
|
7.50
|
USD 83
|
|
|
2024-10-03 |
2024-09-04 |
S
Sale
|
KCK LTD.
Large shareholder
|
14
-0.0%
7.50
USD 105
|
14
-0.0%
|
7.50
|
USD 105
|
|
|
2024-10-03 |
2024-09-03 |
S
Sale
|
KCK LTD.
Large shareholder
|
2,093
-0.0%
7.60
USD 15,907
|
2,093
-0.0%
|
7.60
|
USD 15,907
|
|
|
2024-10-03 |
2024-08-30 |
S
Sale
|
KCK LTD.
Large shareholder
|
4,314
-0.1%
7.76
USD 33,477
|
4,314
-0.1%
|
7.76
|
USD 33,477
|
|
|
2024-05-03 |
2024-05-03 |
S
Sale
|
ORBIMED ADVISORS LLC
Large shareholder
|
4,674
-0.1%
14.03
USD 65,576
|
4,674
-0.1%
|
14.03
|
USD 65,576
|
|
|
2024-05-03 |
2024-05-02 |
S
Sale
|
ORBIMED ADVISORS LLC
Large shareholder
|
8,842
-0.3%
14.01
USD 123,876
|
8,842
-0.3%
|
14.01
|
USD 123,876
|
|
|
2024-05-03 |
2024-05-01 |
S
Sale
|
ORBIMED ADVISORS LLC
Large shareholder
|
15,690
-0.5%
14.02
USD 219,974
|
15,690
-0.5%
|
14.02
|
USD 219,974
|
|
|
2024-04-26 |
2024-04-24 |
S
Sale
|
ORBIMED ADVISORS LLC
Large shareholder
|
1,781
-0.1%
14.06
USD 25,041
|
1,781
-0.1%
|
14.06
|
USD 25,041
|
|
|
2024-04-23 |
2024-04-23 |
S
Sale
|
ORBIMED ADVISORS LLC
Large shareholder
|
21,791
-0.6%
14.29
USD 311,393
|
21,791
-0.6%
|
14.29
|
USD 311,393
|
|
|
2024-04-23 |
2024-04-22 |
S
Sale
|
ORBIMED ADVISORS LLC
Large shareholder
|
24,609
-0.7%
14.05
USD 345,756
|
24,609
-0.7%
|
14.05
|
USD 345,756
|
|
|
2024-04-23 |
2024-04-19 |
S
Sale
|
ORBIMED ADVISORS LLC
Large shareholder
|
18,253
-0.5%
14.02
USD 255,907
|
18,253
-0.5%
|
14.02
|
USD 255,907
|
|
|
2024-04-18 |
2024-04-18 |
S
Sale
|
ORBIMED ADVISORS LLC
Large shareholder
|
2,623
-0.1%
14.06
USD 36,879
|
2,623
-0.1%
|
14.06
|
USD 36,879
|
|
|
2024-04-18 |
2024-04-17 |
S
Sale
|
ORBIMED ADVISORS LLC
Large shareholder
|
300
-0.0%
14.15
USD 4,245
|
300
-0.0%
|
14.15
|
USD 4,245
|
|
|
2024-04-18 |
2024-04-16 |
S
Sale
|
ORBIMED ADVISORS LLC
Large shareholder
|
14,069
-0.4%
14.01
USD 197,107
|
14,069
-0.4%
|
14.01
|
USD 197,107
|
|
|
2024-04-15 |
2024-04-12 |
S
Sale
|
ORBIMED ADVISORS LLC
Large shareholder
|
23,101
-0.7%
14.42
USD 333,116
|
23,101
-0.7%
|
14.42
|
USD 333,116
|
|
|
2024-04-15 |
2024-04-11 |
S
Sale
|
ORBIMED ADVISORS LLC
Large shareholder
|
461,899
-11.5%
14.49
USD 6,692,917
|
461,899
-11.5%
|
14.49
|
USD 6,692,917
|
|
|
2024-02-06 |
2024-02-05 |
PS
Planned sale
|
Morrell Martha
Chief Medical Officer
Officer
|
3,446
-4.2%
15.17
USD 52,278
|
3,446
-4.2%
|
15.17
|
USD 52,278
|
|
|
2024-02-06 |
2024-02-02 |
PS
Planned sale
|
Morrell Martha
Chief Medical Officer
Officer
|
14,143
-14.8%
15.07
USD 213,122
|
14,143
-14.8%
|
15.07
|
USD 213,122
|
|
|
2024-02-01 |
2024-02-01 |
PS
Planned sale
|
Morrell Martha
Chief Medical Officer
Officer
|
663
-0.7%
15.04
USD 9,971
|
663
-0.7%
|
15.04
|
USD 9,971
|
|
|
2024-02-01 |
2024-01-31 |
PS
Planned sale
|
Morrell Martha
Chief Medical Officer
Officer
|
1,923
-2.0%
15.08
USD 28,990
|
1,923
-2.0%
|
15.08
|
USD 28,990
|
|
|
2024-02-01 |
2024-01-30 |
PS
Planned sale
|
Morrell Martha
Chief Medical Officer
Officer
|
11,262
-10.3%
15.10
USD 170,004
|
11,262
-10.3%
|
15.10
|
USD 170,004
|
|
|
2024-01-26 |
2024-01-25 |
PS
Planned sale
|
Morrell Martha
Chief Medical Officer
Officer
|
1
-0.0%
15.00
USD 15
|
1
-0.0%
|
15.00
|
USD 15
|
|
|
2024-01-26 |
2024-01-24 |
PS
Planned sale
|
Morrell Martha
Chief Medical Officer
Officer
|
827
-0.8%
15.03
USD 12,426
|
827
-0.8%
|
15.03
|
USD 12,426
|
|
|
2023-12-28 |
2023-12-27 |
PS
Planned sale
|
Morrell Martha
Chief Medical Officer
Officer
|
13,300
-10.8%
10.12
USD 134,648
|
13,300
-10.8%
|
10.12
|
USD 134,648
|
|
|
2023-12-28 |
2023-12-26 |
PS
Planned sale
|
Morrell Martha
Chief Medical Officer
Officer
|
102
-0.1%
10.00
USD 1,020
|
102
-0.1%
|
10.00
|
USD 1,020
|
|
|
2023-12-22 |
2023-12-20 |
PS
Planned sale
|
Morrell Martha
Chief Medical Officer
Officer
|
2,730
-2.2%
10.14
USD 27,695
|
2,730
-2.2%
|
10.14
|
USD 27,695
|
|
|
2023-12-07 |
2023-12-06 |
PS
Planned sale
|
Morrell Martha
Chief Medical Officer
Officer
|
11,005
-8.0%
8.16
USD 89,773
|
11,005
-8.0%
|
8.16
|
USD 89,773
|
|
|
2023-12-01 |
2023-12-01 |
S
Sale
|
KCK LTD.
Large shareholder
|
3,241
-0.1%
8.73
USD 28,294
|
3,241
-0.1%
|
8.73
|
USD 28,294
|
|
|
2023-12-01 |
2023-11-30 |
S
Sale
|
KCK LTD.
Large shareholder
|
7,282
-0.1%
8.84
USD 64,373
|
7,282
-0.1%
|
8.84
|
USD 64,373
|
|
|
2023-12-01 |
2023-11-29 |
S
Sale
|
KCK LTD.
Large shareholder
|
5,644
-0.1%
8.72
USD 49,216
|
5,644
-0.1%
|
8.72
|
USD 49,216
|
|
|
2023-11-29 |
2023-11-28 |
S
Sale
|
KCK LTD.
Large shareholder
|
4,681
-0.1%
8.75
USD 40,959
|
4,681
-0.1%
|
8.75
|
USD 40,959
|
|
|
2023-11-29 |
2023-11-27 |
S
Sale
|
KCK LTD.
Large shareholder
|
6,490
-0.1%
8.96
USD 58,150
|
6,490
-0.1%
|
8.96
|
USD 58,150
|
|
|
2023-10-04 |
2023-10-03 |
S
Sale
|
ORBIMED ADVISORS LLC
Large shareholder
|
700
-0.0%
9.02
USD 6,314
|
700
-0.0%
|
9.02
|
USD 6,314
|
|
|
2023-10-04 |
2023-10-02 |
S
Sale
|
ORBIMED ADVISORS LLC
Large shareholder
|
7,614
-0.2%
9.08
USD 69,135
|
7,614
-0.2%
|
9.08
|
USD 69,135
|
|
|
2022-11-23 |
2022-11-22 |
B
Purchase
|
Accelmed Partners II L.P.
Large shareholder
|
62,398
+1.4%
1.50
USD 93,535
|
62,398
+1.4%
|
1.50
|
USD 93,535
|
|
|
2022-11-23 |
2022-11-21 |
B
Purchase
|
Accelmed Partners II L.P.
Large shareholder
|
327,893
+8.1%
1.50
USD 491,512
|
327,893
+8.1%
|
1.50
|
USD 491,512
|
|
|
2022-06-09 |
2022-06-08 |
PS
Planned sale
|
Ridley Irina
General Counsel and Secretary
Officer
|
2,500
-3.9%
5.78
USD 14,445
|
2,500
-3.9%
|
5.78
|
USD 14,445
|
|
|
2022-03-01 |
2022-02-28 |
PS
Planned sale
|
Ridley Irina
General Counsel and Secretary
Officer
|
1,470
-18.1%
7.54
USD 11,082
|
1,470
-18.1%
|
7.54
|
USD 11,082
|
|
|
2021-04-23 |
2021-04-21 |
B
Purchase
|
Norton Evan
Non-Executive Director
|
588,235
+inf%
17.00
USD 9,999,995
|
588,235
+inf%
|
17.00
|
USD 9,999,995
|
|
|
2021-04-23 |
2021-04-21 |
B
Purchase
|
ORBIMED ADVISORS LLC
Large shareholder
|
235,000
+inf%
17.00
USD 3,995,000
|
235,000
+inf%
|
17.00
|
USD 3,995,000
|
|
|
2021-04-23 |
2021-04-21 |
B
Purchase
|
Accelmed Partners II L.P.
Large shareholder
|
588,235
+inf%
17.00
USD 9,999,995
|
588,235
+inf%
|
17.00
|
USD 9,999,995
|
|
|
2021-04-23 |
2021-04-21 |
B
Purchase
|
Fischer Frank M
Non-Executive Director
|
50,000
+115.5%
17.00
USD 850,000
|
50,000
+115.5%
|
17.00
|
USD 850,000
|
|
|
2021-04-23 |
2021-04-21 |
B
Purchase
|
Garfield Greg Shaw
Non-Executive Director
|
13,235
+51.7%
17.00
USD 224,995
|
13,235
+51.7%
|
17.00
|
USD 224,995
|
|
|
2021-04-23 |
2021-04-21 |
B
Purchase
|
Ridley Irina
General Counsel and Secretary
Officer
|
2,352
+inf%
17.00
USD 39,984
|
2,352
+inf%
|
17.00
|
USD 39,984
|
|
